| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |